Administration algorithm of erythropoiesis stimulating agents for darbepoetin alfa in hemodialysis patients: a randomized controlled study
Not Applicable
- Conditions
- Patients treated with maintenance hemodialysis
- Registration Number
- JPRN-UMIN000013846
- Lead Sponsor
- Yokodai Central Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with chronic inflammation, malignant disorder, severe congestive heart failure, respiratory organs, and liver disorder (2) Patients who are receiving dialysis modalities other than hemodialysis (3) Patients judged as ineligible for this study by the researcher
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method